XML 11 R1.htm IDEA: XBRL DOCUMENT v3.23.2
Document And Entity Information - USD ($)
12 Months Ended
Mar. 31, 2023
Jul. 13, 2023
Sep. 30, 2022
Document Information [Line Items]      
Entity Central Index Key 0000088948    
Entity Registrant Name Seneca Foods Corporation    
Amendment Flag true    
Current Fiscal Year End Date --03-31    
Document Fiscal Period Focus FY    
Document Fiscal Year Focus 2023    
Document Type 10-K/A    
Document Annual Report true    
Document Period End Date Mar. 31, 2023    
Document Transition Report false    
Entity File Number 0-01989    
Entity Incorporation, State or Country Code NY    
Entity Tax Identification Number 16-0733425    
Entity Address, Address Line One 350 WillowBrook Office Park    
Entity Address, City or Town Fairport    
Entity Address, State or Province NY    
Entity Address, Postal Zip Code 14450    
City Area Code 585    
Local Phone Number 495-4100    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Accelerated Filer    
Entity Small Business false    
Entity Emerging Growth Company false    
ICFR Auditor Attestation Flag true    
Document Financial Statement Error Correction [Flag] false    
Entity Shell Company false    
Entity Public Float     $ 300,641,214
Amendment Description This Amendment No. 1 on Form 10-K/A (“Amendment No. 1”) amends the Annual Report on Form 10-K of Seneca Foods Corporation (the “Company”) for the year ended March 31, 2023 as originally filed with the Securities and Exchange Commission (the “SEC”) on June 13, 2023 (the “Original Filing”).   This Amendment No. 1 amends the Original Filing to reflect the restatement of the Company’s audited Consolidated Financial Statements for the years ended March 31, 2023 and 2022 in order to correct an error related to the Company’s accounting for valuing inventory using the LIFO method, as more fully described in Note 2 to the Consolidated Financial Statements contained in this Amendment No. 1.   The restatement of the Company’s prior period financial statements to reflect this error (i) increases cost of products sold by $31.6 million and $6.3 million in fiscal years 2023 and 2022, respectively and (ii) reduces net earnings by $23.9 million and $4.8 million in fiscal years 2023 and 2022, respectively, from the amounts previously reported in the Original Filing.   The foregoing changes are solely related to the valuation of inventory under the LIFO method and have no impact on results under the first-in, first out (FIFO) method of inventory accounting. As such, the adjustments described above are entirely non-cash: there is no impact on the Company’s cash position, cash flow, revenues, or liquidity. There is no impact on the Company’s financial covenants contained within its credit agreements, which are based on FIFO results. There is no impact on Adjusted Annual Earnings, which the Company determined to be its most important financial performance measure in its most recently filed Proxy Statement.   In connection with the LIFO valuation error, the Company’s management identified a material weakness in its internal control over financial reporting. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of the financial statements will not be prevented or detected and corrected on a timely basis. For a discussion of management’s consideration of the material weakness identified, see Item 9A. Controls and Procedures included in this Amendment.   Revisions to the Original Filing have been made to the following sections:   ● Part I, Item 1 – Business (specifically the information under the subheading “Seasonality”)   ● Part I, Item 1A – Risk Factors (specifically the information under the risk factor “Tax legislation could impact future cash flows.”   ● Part II, Item 7 - Management’s Discussion and Analysis of Financial Condition and Results of Operations (originally included in Exhibit 13 to the Original Filing)   ● Part II, Item 8 - Financial Statements and Supplementary Data (originally included in Exhibit 13 to the Original Filing)   ● Part II, Item 9A - Controls and Procedures   ● Part IV, Item 15 - Exhibits and Financial Statement Schedules   In addition, the Company’s principal executive officer and principal financial officer have provided new certifications dated as of the date of this filing in connection with this Amendment No. 1 (Exhibits 31.1, 31.2, and 32).   Except as described above, this Amendment No. 1 does not amend, update or change any other disclosures in the Original Filing. In addition, the information contained in this Amendment No. 1 does not reflect events occurring after the filing of the Original Filing and does not modify or update the disclosures therein, except as specifically identified above. Among other things, forward-looking statements made in the Original Filing have not been revised to reflect events, results or developments that occurred or facts that became known to us after the date of the Original Filing, other than the restatement, and such forward-looking statements should be read in conjunction with our filings with the SEC, including those subsequent to the filing of the Original Filing.    
Auditor Name Plante Moran, P.C.    
Auditor Firm ID 6581    
Auditor Location Southfield, Michigan    
Common Class B [Member]      
Document Information [Line Items]      
Title of 12(b) Security Common Stock Class B, $.25 Par    
Trading Symbol SENEB    
Security Exchange Name NASDAQ    
Entity Common Stock, Shares Outstanding   1,708,781  
Common Class A [Member]      
Document Information [Line Items]      
Title of 12(b) Security Common Stock Class A, $.25 Par    
Trading Symbol SENEA    
Security Exchange Name NASDAQ    
Entity Common Stock, Shares Outstanding   5,884,855